TrialJournal of immunotherapy (Hagerstown, Md. : 1997)

A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma.

Valerie P Grignol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.